VedaBio announced the appointment of Rachel Jones as Chief Commercial Officer, bringing over 25 years of experience in molecular diagnostics and a proven track record of successfully commercializing groundbreaking solutions in clinical diagnostics. Her appointment marks a pivotal step as VedaBio advances the development and commercialization of its revolutionary CRISPR-based molecular detection platform.